APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications.

MLA

Tai, Yu-Tzu, et al. “APRIL Signaling via TACI Mediates Immunosuppression by T Regulatory Cells in Multiple Myeloma: Therapeutic Implications.” Leukemia, vol. 33, no. 2, Feb. 2019, pp. 426–38. EBSCOhost, https://doi.org/10.1038/s41375-018-0242-6.

APA

Tai, Y.-T., Lin, L., Xing, L., Cho, S.-F., Yu, T., Acharya, C., Wen, K., Hsieh, P. A., Dulos, J., van Elsas, A., Munshi, N., Richardson, P., & Anderson, K. C. (2019). APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia, 33(2), 426–438. https://doi.org/10.1038/s41375-018-0242-6

Chicago

Tai, Yu-Tzu, Liang Lin, Lijie Xing, Shih-Feng Cho, Tengteng Yu, Chirag Acharya, Kenneth Wen, et al. 2019. “APRIL Signaling via TACI Mediates Immunosuppression by T Regulatory Cells in Multiple Myeloma: Therapeutic Implications.” Leukemia 33 (2): 426–38. doi:10.1038/s41375-018-0242-6.